Literature DB >> 17916029

Use of bone morphogenetic proteins for augmentation of bone regeneration.

Carl A Kirker-Head1, Randy J Boudrieau, Karl H Kraus.   

Abstract

A large body of preclinical and clinical data now documents that recombinant BMPs can be used for skeletal regeneration in humans and animals. Recombinant human BMP-2 and BMP-7 have been approved for use in human patients with long-bone fractures and nonunions and in patients undergoing lumbar fusion or various maxillofacial and dental regenerative procedures. These products have also been made available for veterinary use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916029     DOI: 10.2460/javma.231.7.1039

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Age and skeletal sites affect BMP-2 responsiveness of human bone marrow stromal cells.

Authors:  Anna Maria Osyczka; Monika Damek-Poprawa; Aleksandra Wojtowicz; Sunday O Akintoye
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

2.  Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases.

Authors:  Cory B Pinel; G Elizabeth Pluhar
Journal:  Can Vet J       Date:  2012-07       Impact factor: 1.008

3.  Bone morphogenetic protein 2 signaling in osteoclasts is negatively regulated by the BMP antagonist, twisted gastrulation.

Authors:  Lan Pham; Kayla Beyer; Eric D Jensen; Julio Sotillo Rodriguez; Julia Davydova; Masato Yamamoto; Anna Petryk; Rajaram Gopalakrishnan; Kim C Mansky
Journal:  J Cell Biochem       Date:  2011-03       Impact factor: 4.429

Review 4.  Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review.

Authors:  Yuchen Wang; Maureen R Newman; Danielle S W Benoit
Journal:  Eur J Pharm Biopharm       Date:  2018-02-19       Impact factor: 5.571

5.  Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors.

Authors:  Eric D Jensen; Lan Pham; Charles J Billington; Kelly Espe; Ann E Carlson; Jennifer J Westendorf; Anna Petryk; Rajaram Gopalakrishnan; Kim Mansky
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

6.  Reconstruction of comminuted long-bone fracture using CF/CPC scaffolds manufactured by rapid prototyping.

Authors:  Sheng-Li Huang; Bo Wen; Wei-Guo Bian; Hong-Wei Yan
Journal:  Med Sci Monit       Date:  2012-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.